{"id": "1379407675688161281", "creation": 1617711392.0, "user_id": "1128640871270842368", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 4, "quote_count": 2}}, "text": "53Biologics is collaborating with @DyadicInc on the development of DYAI-100, a #vaccine candidate against #COVID19, which is moving towards first-in-human Phase 1 clinical trial.\n\n#biotech #53Biologics #biotechnology #innovation https://t.co/4MgS4JAJqZ", "first_save": 1634559108.199414, "hashtags": ["#VACCINE", "#COVID19", "#BIOTECH", "#53BIOLOGICS", "#BIOTECHNOLOGY", "#INNOVATION"]}